Responsible Side Effects Management in Oncology (R-SEMO)

University Hospital "Sestre Milosrdnice"

Status: Completed

Conditions: Antineoplastic Treatment; Oncology; Pharmacovigilance

Study type: Observational

Funder types: Other

Identifiers

NCT04623437

2312201522122016

Details and patient eligibility

About

Study of pharmacovigilance in oncology. Monitoring and management of AEs during antineoplastic treatment.

Full description

Monitoring and management of AE's during antineoplastic treatment. Comparison of AE's reported by patient with the ones recognised by the oncologist, and vice versa, during antineoplastic treatment.

Enrollment: 267 patients

Sex: All

Ages: 18 to 75 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

all cancer patients receiving systemic antineoplastic treatment, ECOG 0-2

Exclusion criteria

age <18, >75; other active and severe comorbidities; no solid cancer; IUC patients